Daniel M Muldoon

Most-cited papers

1. Decreased affinity for efflux transporters increases brain penetrance and molecular targeting of a PI3K/mTOR inhibitor in a mouse model of glioblastoma.

   C. M. Becker, R. Oberoi, S. J. McFarren, Daniel M Muldoon +7 more

   2015Neuro-Oncology39 citations Open access

   Semantic Scholar

   Save

2. Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer

   R. Thummalapalli, B. Ricciuti, C. Bandlamudi, Daniel M Muldoon +24 more

   2023Clinical Cancer Research28 citations Open access

   Semantic Scholar

   Save

3. miR-29 Regulates Type VII Collagen in Recessive Dystrophic Epidermolysis Bullosa

   M. Vanden Oever, Daniel M Muldoon, Wendy Mathews, Ron T. McElmurry +1 more

   2016Journal of Investigative Dermatology26 citations Open access

   Semantic Scholar

   Save

4. Clinicopathologic, Genomic, and Immunophenotypic Landscape of ATM Mutations in Non–Small Cell Lung Cancer

   B. Ricciuti, A. Elkrief, J. Alessi, Xinan Wang +29 more

   2023Clinical Cancer Research20 citations Open access

   Semantic Scholar

   Save

5. Fludarabine modulates expression of type VII collagen during haematopoietic stem cell transplantation for recessive dystrophic epidermolysis bullosa

   M. Vanden Oever, Daniel M Muldoon, Wendy Mathews, Jakub Tolar

   2020British Journal of Dermatology7 citations Open access

   Semantic Scholar

   Save

6. Lipoprotein particle alterations due to androgen therapy in individuals with dyskeratosis congenita

   Mone’t B. Thompson, Daniel M Muldoon, K. D. de Andrade, N. Giri +4 more

   2021EBioMedicine3 citations Open access

   Semantic Scholar

   Save

7. Decrease in T-Lymphocyte Mitochondrial DNA Copy Number Is Associated with Acute Graft Versus Host Disease

   B. Thyagarajan, Erin Cassidy, V. Nguyen, R. Shanley +5 more

   20201 citations Open access

   Semantic Scholar

   Save

8. Abstract 5214: Expanding the spectrum of germline-driven cancers by leveraging population-scale targeted tumor and normal sequencing

   Miika Mehine, Rebecca Caeser, Y. Kemel, Daniel M Muldoon +15 more

   2023Cancer Research0 citations

   Semantic Scholar

   Save

9. Clinical and molecular features of long-term response to anti-PD-(L)1 therapy in patients with advanced non-small cell lung cancer.

   R. Thummalapalli, B. Ricciuti, C. Bandlamudi, Daniel M Muldoon +14 more

   2023Journal of Clinical Oncology0 citations Open access

   Semantic Scholar

   Save

10. MODL-17. SHP2 INHIBITORS SHOW ACTIVITY AGAINST NF1-DEFICIENT GLIOMAS AND ENHANCE MAPK PATHWAY INHIBITION IN BRAF-V600E MUTANT GLIOMAS

    Daniel M Muldoon, Guisheng Zhao, Carly Batt, Mallika Singh +1 more

    2020Neuro-Oncology0 citations Open access

    Semantic Scholar

    Save

11. DIPG-19. REVERSAL OF CANCER GENE EXPRESSION IDENTIFIES NOVEL THERAPEUTICS FOR DIFFUSE INTRINSIC PONTINE GLIOMA

    Guisheng Zhao, Patrick A. Newbury, William Z. D. Zeng, Daniel M Muldoon +5 more

    2019Neuro-Oncology0 citations Open access

    Semantic Scholar

    Save

12. THER-17. BRAF-V600E DEGRADATION AS A THERAPEUTIC STRATEGY IN BRAF-V600E MUTANT GLIOMAS

    Guisheng Zhao, Daniel M Muldoon, Xiu-Lei Mo, Cong Tang +4 more

    2019Neuro-Oncology0 citations Open access

    Semantic Scholar

    Save

13. 390 miR-29 regulates type VII collagen in individuals with recessive dystrophic epidermolysis bullosa (RDEB)

    M. Vanden Oever, Daniel M Muldoon, J. Tolar

    20160 citations Open access

    Semantic Scholar

    Save